Skip to main content
Top
Published in: Virchows Archiv 2/2014

01-08-2014 | Case Report

Diffuse glutamine synthetase overexpression restricted to areas of peliosis in a β-catenin-activated hepatocellular adenoma: a potential pitfall in glutamine synthetase interpretation

Authors: Ryan S. Berry, Rama R. Gullapalli, Jin Wu, Katherine Morris, Joshua A. Hanson

Published in: Virchows Archiv | Issue 2/2014

Login to get access

Abstract

Hepatocellular adenomas have recently been classified into four subtypes based on molecular findings: hepatocyte nuclear factor 1α (HNF1α) inactivated, inflammatory/telangiectatic, β-catenin activated, and unclassifiable. β-catenin-activated adenomas have the potential for malignant transformation and are thus important to recognize. Diffuse glutamine synthetase immunohistochemical positivity has been shown to be a reliable surrogate marker for β-catenin activation, though variations in staining patterns may be difficult to interpret. We report a case of a peliotic adenoma that was morphologically consistent with a β-catenin wild-type hepatocellular adenoma but harbored a β-catenin mutation by molecular analysis. The tumor lacked nuclear β-catenin positivity and demonstrated a hitherto undescribed pattern of glutamine synthetase overexpression restricted to areas of peliosis with mostly negative staining in non-peliotic areas. This pattern was initially interpreted as physiologic and may represent a potential pitfall in glutamine synthetase interpretation.
Literature
1.
go back to reference Zucman-Rossi J, Jeannot E, Nhieu JT et al (2006) Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43(3):515–524PubMedCrossRef Zucman-Rossi J, Jeannot E, Nhieu JT et al (2006) Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43(3):515–524PubMedCrossRef
2.
go back to reference Bioulac-Sage P, Rebouissou S, Thomas C et al (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46(3):740–748PubMedCrossRef Bioulac-Sage P, Rebouissou S, Thomas C et al (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46(3):740–748PubMedCrossRef
3.
go back to reference Bioulac-Sage P, Laumonier H, Couchy G et al (2009) Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 50(2):481–489PubMedCrossRef Bioulac-Sage P, Laumonier H, Couchy G et al (2009) Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 50(2):481–489PubMedCrossRef
4.
go back to reference Bioulac-Sage P, Cubel G, Taouji S et al (2012) Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes. Am J Surg Pathol 36(11):1691–1699PubMedCrossRef Bioulac-Sage P, Cubel G, Taouji S et al (2012) Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes. Am J Surg Pathol 36(11):1691–1699PubMedCrossRef
5.
go back to reference Gebhardt R, Baldysiak-Figiel A, Krügel V, Ueberham E, Gaunitz F (2007) Hepatocellular expression of glutamine synthetase: an indicator of morphogen actions as master regulators of zonation in adult liver. Prog Histochem Cytochem 41(4):201–266PubMedCrossRef Gebhardt R, Baldysiak-Figiel A, Krügel V, Ueberham E, Gaunitz F (2007) Hepatocellular expression of glutamine synthetase: an indicator of morphogen actions as master regulators of zonation in adult liver. Prog Histochem Cytochem 41(4):201–266PubMedCrossRef
6.
go back to reference Ueberham E, Arendt E, Starke M, Bittner R, Gebhardt R (2004) Reduction and expansion of the glutamine synthetase expressing zone in livers from tetracycline controlled TGF-beta1 transgenic mice and multiple starved mice. J Hepatol 41(1):75–81PubMedCrossRef Ueberham E, Arendt E, Starke M, Bittner R, Gebhardt R (2004) Reduction and expansion of the glutamine synthetase expressing zone in livers from tetracycline controlled TGF-beta1 transgenic mice and multiple starved mice. J Hepatol 41(1):75–81PubMedCrossRef
7.
go back to reference Paxian M, Rensing H, Geckeis K et al (2003) Perflubron emulsion in prolonged hemorrhagic shock: influence on hepatocellular energy metabolism and oxygen-dependent gene expression. Anesthesiology 98(6):1391–1399PubMedCrossRef Paxian M, Rensing H, Geckeis K et al (2003) Perflubron emulsion in prolonged hemorrhagic shock: influence on hepatocellular energy metabolism and oxygen-dependent gene expression. Anesthesiology 98(6):1391–1399PubMedCrossRef
8.
go back to reference Stevens WE, Patil A. Vascular Disease of the Liver. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran’s gastrointestinal and liver disease. 9th ed. Philadelphia, PA: Saunders; 2010:1381 Stevens WE, Patil A. Vascular Disease of the Liver. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran’s gastrointestinal and liver disease. 9th ed. Philadelphia, PA: Saunders; 2010:1381
9.
go back to reference Cho SJ, Wanless I, Paradis V et al (2011) FNH-like lesions and glutamine synthetase expression in the liver in hereditary hemorrhagic telangiectasia (abstract). Mod Path 24:364A Cho SJ, Wanless I, Paradis V et al (2011) FNH-like lesions and glutamine synthetase expression in the liver in hereditary hemorrhagic telangiectasia (abstract). Mod Path 24:364A
10.
go back to reference Bioulac-Sage P, Cubel G, Balabaud C, Zucman-Rossi J (2011) Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Semin Liver Dis 31(1):91–103PubMedCrossRef Bioulac-Sage P, Cubel G, Balabaud C, Zucman-Rossi J (2011) Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Semin Liver Dis 31(1):91–103PubMedCrossRef
11.
go back to reference Bioulac-Sage P, Taouji S, Le Bail B, Possenti L, Balabaud C (2013) Value and limits of routine histology alone or combined with glutamine synthetase immunostaining in the diagnosis of hepatocellular adenoma subtypes on surgical specimens. Int J Hepatol 2013:417323PubMedCentralPubMed Bioulac-Sage P, Taouji S, Le Bail B, Possenti L, Balabaud C (2013) Value and limits of routine histology alone or combined with glutamine synthetase immunostaining in the diagnosis of hepatocellular adenoma subtypes on surgical specimens. Int J Hepatol 2013:417323PubMedCentralPubMed
12.
go back to reference Austinat M, Dunsch R, Wittekind C, Tannapfel A, Gebhardt R, Gaunitz F (2008) Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma. Mol Cancer 7:21PubMedCentralPubMedCrossRef Austinat M, Dunsch R, Wittekind C, Tannapfel A, Gebhardt R, Gaunitz F (2008) Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma. Mol Cancer 7:21PubMedCentralPubMedCrossRef
Metadata
Title
Diffuse glutamine synthetase overexpression restricted to areas of peliosis in a β-catenin-activated hepatocellular adenoma: a potential pitfall in glutamine synthetase interpretation
Authors
Ryan S. Berry
Rama R. Gullapalli
Jin Wu
Katherine Morris
Joshua A. Hanson
Publication date
01-08-2014
Publisher
Springer Berlin Heidelberg
Published in
Virchows Archiv / Issue 2/2014
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-014-1620-8

Other articles of this Issue 2/2014

Virchows Archiv 2/2014 Go to the issue

Letter to the Editor

Authors’ response